logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Cerulean Pharma Inc.

Calculating rank
USPTO Granted Patents = 21

% Expired Patents = 61.9



Forward Citations = 175

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Mark E Davis (15 out of 137 patents)

silverMedal Jianjun Cheng (15 out of 23 patents)

bronzeMedal Kay T Khin (14 out of 15 patents)

4.  J Michael Ramstack (6 out of 44 patents)

5.  John Podobinski (5 out of 6 patents)

6.  David S Dickey (3 out of 5 patents)

7.  Thomas Crawford (1 out of 8 patents)

8.  Kat T Khin (1 out of 1 patent)

9.  Thomas Schluep (1 patent)

10.  Jianjun Cheng (22 patents)

11.  John M Ryan (23 patents)

12.  Scott D Eliasof (2 patents)


21 patents:

1. 9598503 - Methods and systems for polymer precipitation and generation of particles (2017-03-21),
2. 9550860 - Cyclodextrin-based polymers for therapeutics delivery (2017-01-24),
3. 8809492 - Method for fabricating nanoparticles (2014-08-19),
4. 8680202 - Cyclodextrin-based polymers for therapeutics delivery (2014-03-25),
5. 8618240 - Methods and systems for generating nanoparticles (2013-12-31),
6. 8609081 - Cyclodextrin-based polymers for therapeutics delivery (2013-12-17),
7. 8603454 - Cyclodextrin-based polymers for therapeutics delivery (2013-12-10),
8. 8580244 - Cyclodextrin-based polymers for therapeutics delivery (2013-11-12),
9. 8580243 - Cyclodextrin-based polymers for therapeutics delivery (2013-11-12),
10. 8580242 - Cyclodextrin-based polymers for therapeutics delivery (2013-11-12),
11. 8546521 - Method for fabricating nanoparticles (2013-10-01),
12. 8518388 - Cyclodextrin-based polymers for therapeutics delivery (2013-08-27),
13. 8475781 - Cyclodextrin-based polymers for therapeutics delivery (2013-07-02),
14. 8404799 - Methods and systems for generating nanoparticles (2013-03-26),
15. 8404662 - Cyclodextrin-based polymers for therapeutics delivery (2013-03-26),
Company Overview
Cerulean Pharma Inc. is a biopharmaceutical company based in Cambridge, MA, specializing in the development of innovative therapies for cancer treatment. The company focuses on utilizing its proprietary technology platform to create targeted drug delivery systems that enhance the efficacy and safety of therapeutic agents. Cerulean's research emphasizes the intersection of nanotechnology and oncology, aiming to improve patient outcomes through advanced treatment modalities and precision medicine approaches.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

21 Patents

#132 in Cambridge, MA

#946 in Massachusetts

#15,719 in US

#30,018 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Cerulean Pharma Inc.

Forward Citations = 175

8 inventors:

goldMedal Mark E Davis (15 out of 137 patents)

silverMedal Jianjun Cheng (15 out of 23 patents)

bronzeMedal Kay T Khin (14 out of 15 patents)

4.  J Michael Ramstack (6 out of 44 patents)

5.  John Podobinski (5 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cerulean Pharma Inc.. Retrieved from https://idiyas.com/company/cerulean-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…